FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092108542> ?p ?o ?g. }

• W2092108542 endingPage "851" @default.
• W2092108542 startingPage "845" @default.
• W2092108542 abstract "Traumatic brain injury (TBI) is the commonest cause of death and disability in those aged under 40 years. Interleukin-1 receptor antagonist (IL1ra) is an endogenous competitive antagonist at the interleukin-1 type-1 receptor (IL-1R). Antagonism at the IL-1R confers neuroprotection in several rodent models of neuronal injury (i.e., trauma, stroke and excitotoxicity). We describe a single center, phase II, open label, randomized-control study of recombinant human IL1ra (rhIL1ra, anakinra) in severe TBI, at a dose of 100 mg subcutaneously once a day for 5 days in 20 patients randomized 1:1. We provide safety data (primary outcome) in this pathology, utilize cerebral microdialysis to directly determine brain extracellular concentrations of IL1ra and 41 cytokines and chemokines, and use principal component analysis (PCA) to explore the resultant cerebral cytokine profile. Interleukin-1 receptor antagonist was safe, penetrated into plasma and the brain extracellular fluid. The PCA showed a separation in cytokine profiles after IL1ra administration. A candidate cytokine from this analysis, macrophage-derived chemoattractant, was significantly lower in the rhIL1ra-treated group. Our results provide promising data for rhIL1ra as a therapeutic candidate by showing safety, brain penetration and a modification of the neuroinflammatory response to TBI by a putative neuroprotective agent in humans for the first time." @default.
• W2092108542 created "2016-06-24" @default.
• W2092108542 creator A5013479481 @default.
• W2092108542 creator A5014959081 @default.
• W2092108542 creator A5046998828 @default.
• W2092108542 creator A5057778218 @default.
• W2092108542 creator A5064938667 @default.
• W2092108542 creator A5088132218 @default.
• W2092108542 date "2014-02-26" @default.
• W2092108542 modified "2023-10-14" @default.
• W2092108542 title "Recombinant Human Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury: A Phase II Randomized Control Trial" @default.
• W2092108542 cites W1940215351 @default.
• W2092108542 cites W1979679540 @default.
• W2092108542 cites W1981724301 @default.
• W2092108542 cites W1988610853 @default.
• W2092108542 cites W1996884768 @default.
• W2092108542 cites W2023396428 @default.
• W2092108542 cites W2028290269 @default.
• W2092108542 cites W2032541700 @default.
• W2092108542 cites W2034637876 @default.
• W2092108542 cites W2035492426 @default.
• W2092108542 cites W2038720901 @default.
• W2092108542 cites W2040832866 @default.
• W2092108542 cites W2042323213 @default.
• W2092108542 cites W2042412331 @default.
• W2092108542 cites W2050800676 @default.
• W2092108542 cites W2057979643 @default.
• W2092108542 cites W2062611149 @default.
• W2092108542 cites W2065949360 @default.
• W2092108542 cites W2066442550 @default.
• W2092108542 cites W2068861417 @default.
• W2092108542 cites W2072401555 @default.
• W2092108542 cites W2076757725 @default.
• W2092108542 cites W2078515727 @default.
• W2092108542 cites W2087612549 @default.
• W2092108542 cites W2091111800 @default.
• W2092108542 cites W2092334974 @default.
• W2092108542 cites W2093705034 @default.
• W2092108542 cites W2097699694 @default.
• W2092108542 cites W2114684229 @default.
• W2092108542 cites W2123389203 @default.
• W2092108542 cites W2125610020 @default.
• W2092108542 cites W2133703750 @default.
• W2092108542 cites W2141057018 @default.
• W2092108542 cites W2146107139 @default.
• W2092108542 cites W2150238049 @default.
• W2092108542 cites W2156917423 @default.
• W2092108542 cites W4233859297 @default.
• W2092108542 doi "https://doi.org/10.1038/jcbfm.2014.23" @default.
• W2092108542 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4013762" @default.
• W2092108542 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24569690" @default.
• W2092108542 hasPublicationYear "2014" @default.
• W2092108542 type Work @default.
• W2092108542 sameAs 2092108542 @default.
• W2092108542 citedByCount "131" @default.
• W2092108542 countsByYear W20921085422014 @default.
• W2092108542 countsByYear W20921085422015 @default.
• W2092108542 countsByYear W20921085422016 @default.
• W2092108542 countsByYear W20921085422017 @default.
• W2092108542 countsByYear W20921085422018 @default.
• W2092108542 countsByYear W20921085422019 @default.
• W2092108542 countsByYear W20921085422020 @default.
• W2092108542 countsByYear W20921085422021 @default.
• W2092108542 countsByYear W20921085422022 @default.
• W2092108542 countsByYear W20921085422023 @default.
• W2092108542 crossrefType "journal-article" @default.
• W2092108542 hasAuthorship W2092108542A5013479481 @default.
• W2092108542 hasAuthorship W2092108542A5014959081 @default.
• W2092108542 hasAuthorship W2092108542A5046998828 @default.
• W2092108542 hasAuthorship W2092108542A5057778218 @default.
• W2092108542 hasAuthorship W2092108542A5064938667 @default.
• W2092108542 hasAuthorship W2092108542A5088132218 @default.
• W2092108542 hasBestOaLocation W20921085421 @default.
• W2092108542 hasConcept C118552586 @default.
• W2092108542 hasConcept C126322002 @default.
• W2092108542 hasConcept C149892131 @default.
• W2092108542 hasConcept C170493617 @default.
• W2092108542 hasConcept C25498285 @default.
• W2092108542 hasConcept C2776885963 @default.
• W2092108542 hasConcept C2778122271 @default.
• W2092108542 hasConcept C2778690821 @default.
• W2092108542 hasConcept C2779134260 @default.
• W2092108542 hasConcept C2781017439 @default.
• W2092108542 hasConcept C2781228260 @default.
• W2092108542 hasConcept C42219234 @default.
• W2092108542 hasConcept C71924100 @default.
• W2092108542 hasConcept C98274493 @default.
• W2092108542 hasConceptScore W2092108542C118552586 @default.
• W2092108542 hasConceptScore W2092108542C126322002 @default.
• W2092108542 hasConceptScore W2092108542C149892131 @default.
• W2092108542 hasConceptScore W2092108542C170493617 @default.
• W2092108542 hasConceptScore W2092108542C25498285 @default.
• W2092108542 hasConceptScore W2092108542C2776885963 @default.
• W2092108542 hasConceptScore W2092108542C2778122271 @default.
• W2092108542 hasConceptScore W2092108542C2778690821 @default.
• W2092108542 hasConceptScore W2092108542C2779134260 @default.
• W2092108542 hasConceptScore W2092108542C2781017439 @default.
• W2092108542 hasConceptScore W2092108542C2781228260 @default.

• next